Iterum Therapeutics plc Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.73 | -$0.73 | -$0.73 |
Q2 2024 | 0 | -$0.45 | -$0.45 | -$0.45 |
Q3 2024 | 1 | -$0.18 | -$0.18 | -$0.18 |
Q4 2024 | 0 | -$0.20 | -$0.20 | -$0.20 |
Q1 2025 | 0 | -$0.23 | -$0.23 | -$0.23 |
Q2 2025 | 0 | -$0.23 | -$0.23 | -$0.23 |
Q3 2025 | 0 | -$0.22 | -$0.22 | -$0.22 |
Q4 2025 | 0 | -$0.15 | -$0.15 | -$0.15 |
Iterum Therapeutics plc Earnings Date And Information
Iterum Therapeutics plc last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.3 earnings per share for the quarter, topping analysts' consensus estimates of $-0.52 by $0.22. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Iterum Therapeutics plc has generated $-3 earnings per share over the last year ($-2.96 diluted earnings per share) and currently has a price-to-earnings ratio of -0.62. Iterum Therapeutics plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Iterum Therapeutics plc Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/14/2024 | Q2 2024 | -$0.52 | -$0.30 | 0.22 | $0 | $0 |
05/13/2024 | Q1 2024 | -$0.57 | -$0.46 | 0.11 | $0 | $0 |
03/28/2024 | Q4 2023 | -$1.02 | -$0.94 | 0.08 | $0 | $2.62 M |
09/29/2023 | Q3 2023 | -$0.30 | $0 | |||
08/11/2023 | Q2 2023 | -$0.80 | -$0.95 | -0.15 | $0 | |
05/12/2023 | Q1 2023 | -$0.80 | -$0.78 | 0.02 | $0 | |
03/16/2023 | Q4 2022 | -$1.22 | -$0.41 | 0.81 | $0 | |
11/10/2022 | Q3 2022 | -$1.00 | -$2.38 | -1.38 | $0 | |
08/12/2022 | Q2 2022 | -$1.05 | -$0.55 | 0.5 | $0 | |
05/13/2022 | Q1 2022 | -$0.75 | -$0.29 | 0.46 | $0 | |
03/28/2022 | Q4 2021 | -$0.60 | -$0.34 | 0.26 | $0 | |
11/12/2021 | Q3 2021 | $1.80 | $0.31 | -1.49 | $0 | |
08/13/2021 | Q2 2021 | -$0.97 | $0.60 | 1.57 | $0 | |
05/14/2021 | Q1 2021 | -$0.90 | -$12.21 | -11.31 | $0 | |
03/12/2021 | Q4 2020 | -$3.00 | -$4.13 | -1.13 | $0 | |
11/16/2020 | Q3 2020 | -$6.45 | -$8.97 | -2.52 | $0 | |
08/06/2020 | Q2 2020 | -$12.29 | -$12.03 | 0.26 | $0 | |
05/14/2020 | Q1 2020 | -$20.24 | -$16.24 | 4 | $0 | |
03/12/2020 | Q4 2019 | -$27.74 | -$23.91 | 3.83 | $0 | |
11/12/2019 | Q3 2019 | -$28.04 | -$32.19 | -4.15 | $93,333 | $0 |
Iterum Therapeutics plc Earnings: Frequently Asked Questions
-
When is Iterum Therapeutics plc's earnings date?
Iterum Therapeutics plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Iterum Therapeutics plc beat their earnings estimates last quarter?
In the previous quarter, Iterum Therapeutics plc (:ITRM) reported $-0.3 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.52 by $0.22.
-
How can I listen to Iterum Therapeutics plc's earnings conference call?
The conference call for Iterum Therapeutics plc's latest earnings report can be listened to online.
-
How can I read Iterum Therapeutics plc's conference call transcript?
The conference call transcript for Iterum Therapeutics plc's latest earnings report can be read online.
-
How much profit does Iterum Therapeutics plc generate each year?
Iterum Therapeutics plc (:ITRM) has a recorded net income of $0. Iterum Therapeutics plc has generated $-2.96 earnings per share over the last four quarters.
-
What is Iterum Therapeutics plc's price-to-earnings ratio?
Iterum Therapeutics plc (:ITRM) has a price-to-earnings ratio of -0.62 and price/earnings-to-growth ratio is -0.03.